Viral hepatitis – types A, B, C, D and E – are the main causes of acute liver infections. Every 30 seconds from the disease caused by hepatitis, a person dies Healthcare On the International Hepatitis Day, which is celebrated annually on July 28, the World Health Organization again called on the Government and partners of the WHO to accelerate efforts to eliminate viral hepatitis and reduction of mortality from liver cancer. 62 ~ “Every 30 seconds, someone dies from a serious liver disease or cancer caused by hepatitis. At the same time, we have all the tools to stop this epidemic, ”emphasized the general director of the tedos adkhan Goebreesus. 62 >Viral hepatitis – types A, B, C, D≈ NBSP; and E – are the main causes of acute liver infections, but only hepatitis B, C and D≈ NBSP; can lead to chronic diseases that significantly increase the risk of cirrhosis, liver failure and cancer liver. most infected people do not suspect their illness. Hepatitis B, C and D&PP; NBSP; more than 300 million people around the world are sick. These viruses cause over 1.3 million deaths annually, mainly due to cirrhosis and liver cancer. revision of hepatitis status d 62 > 62 > 62 ~The International Cancer Research Agency has recently appropriated d & nbsp; the status of a carcinogen for humans, along with hepatitis B and S. Hepatitis D, which develops only in people who are already infected with hepatitis B, increases the risk of liver cancer two to six times compared to one hepatitis B. Consistency of the status of the disease has become an important step in the global struggle for the global struggle for the global struggle Increasing awareness, improving monitoring and expanding access to new treatment methods. ~ 60 > “In 2024 WHO I have issued recommendations for testing and diagnosis of hepatitis B and d & nbsp; and continues to track the results of clinical tests of innovative drugs against hepatitis D ”,” said Dr. Meg Dogerti, Director of WHO in science. 62 ~ 60 > treatment with oral drugs allows you to cure hepatitis C in two to three months and effectively control hepatitis B during lifelong therapy. 62 ~ > 62 ~ possibilities for treatment. Hepatitis D≈ NBSP; continue to develop. Nevertheless, a decrease in the number of cases of cirrhosis and liver cancer is possible only if a significant expansion and deepening of vaccination, testing and therapy programs is possible. 62 ~~ 60 > progress is noticeable 62 > 62 > 62 > 62 > 62 > 62 > 62Experts are encouraged by the fact that most countries with low and average income already have strategic plans to combat hepatitis, and progress in national programs is noticeable. So, in 2025, the number of countries reporting on national hepatitis plans increased from 59 to 123. ~ 60 > in 2025 129 countries adopted a hepatitis in pregnant women testing policy, while in 2024 there were 106 such. In addition, 147 countries implemented vaccination newborn dose against hepatitis B – and this is significant progress compared to 138 countries two years earlier. ~ 60 > gaps remain serious gaps in testing and treatment remain. According to the global report on hepatitis of 2024, only every eighth patient with hepatitis B was diagnosed and a little more than a third – hepatitis C. Things are even worse with the treatment: only three percent & nbsp; Patients with hepatitis B and 20 percent – hepatitis C receive the necessary therapy. These indicators are significantly lagging behind the targets of WHO for 2025, when it was planned to diagnose 60 percent and treat 50 percent of patients. 60 > fulfillment of the WHO to 2030 will save 2.8 million lives and prevent 9.8 million new stuctions. At the same time, against the background of the reduction of international support, countries need to increase internal investments, integrate services, improve data collection, ensure the availability of drugs and deal with the stigmatization of patients.